#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Plasma cell myeloma Paget's disease of the vulva Pulmonary tuberculosis Liposarcoma Mantle cell lymphoma stage III Hypophosphatasia Fusarium infection Human papilloma virus immunisation Arterial disorder PIK3CA-activated mutation Glycogen storage disease type I Depression Non-Hodgkin's lymphoma Small cell lung cancer extensive stage Bile acid synthesis disorder More trials…

    Learn about Rare Diseases

    Proteus syndrome – Diagnostics Leiomyosarcoma recurrent – Diagnostics Hereditary hypophosphataemic rickets – Treatment Factor IX deficiency – Life with Disease Hairy cell leukaemia – Treatment Aicardi-Goutieres syndrome – Trials in Disease Hairy cell leukaemia recurrent – Trials in Disease Pemphigus – Basic Information Systemic mastocytosis – Basic Information Netherton’s syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Metoclopramide Nandrolone Decanoate Milnacipran Hydrochloride Ht-29-A Prasugrel Fexofenadine Rbl007.2 Clofarabine L-Glutamic Acid ZILEBESIRAN ALN-961583 Quinine Dihydrochloride Sotorasib Azd8421 Serine Follitropin Beta Pemetrexed Diacid Monohydrate Chloroprocaine Hydrochloride Opium, Standardized Powdered Onasemnogene Abeparvovec More therapies…

    Learn about Your Condition

    Optic glioma Hypoaesthesia Chronic fatigue syndrome Oxygen therapy Turner's syndrome Papilloma viral infection Parkinson's disease Deafness Anal cancer Cognitive disorder Hypophosphatasia Neoplasm malignant Carpal tunnel syndrome Pyoderma gangrenosum Shprintzen-Goldberg syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Biliary tract operation

  • Study of Durvalumab, Tremelimumab, and Capecitabine for Patients with Biliary Tract Cancer in an Adjuvant Setting

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Biliary adenoma
    • Biliary tract operation
    • Gallbladder cancer
    Investigated Drugs:
    • Capecitabine
    • Durvalumab
    • Tremelimumab
    Germany

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!